Waldencast Business Summary

Waldencast plc (WALD) operates as a global multi-brand beauty and wellness platform, generating revenue primarily through the wholesale and direct-to-consumer (DTC) sale of premium skincare and cosmetic products. The company’s business model is structured around two core segments: Obagi Medical, a high-margin clinical skincare line focused on dermatology and medical aesthetics, and Milk Makeup, a clean-beauty brand targeting the Gen Z and Millennial demographics. Revenue is predominantly derived from physical product sales (over 98%), supplemented by licensing royalties. As of early 2026, Waldencast is positioned as a consolidator of purpose-driven brands, though it currently faces high leverage and flat revenue growth compared to its peers. Its primary direct competitors include The Beauty Health Company (SKIN), The Honest Company (HNST), and FitLife Brands (FTLF), while it competes for market share against legacy conglomerates like L'Oréal and Estée Lauder by emphasizing agility and brand-led authenticity. The leadership team is anchored by co-founders Michel Brousset (CEO) and Felipe Dutra (Executive Chairman), both of whom possess significant pedigree from L'Oréal and Anheuser-Busch InBev, respectively. They are joined by co-founder and Chief Growth Officer Hind Sebti, a veteran of Procter & Gamble and L'Oréal, and CFO Manuel Manfredi. The board of directors features notable figures such as Roberto Thompson Motta, a co-founder of 3G Capital, and Aaron Chatterley, founder of Feelunique. Major institutional backing and significant ownership stakes are held by Sijue Dai, Zeno Equity Partners, and Waldencast Long-Term Capital LLC. This executive group is currently focused on a strategic turnaround for the Milk Makeup segment and expanding Obagi’s footprint in the medical aesthetics market following the recent acquisition of Novaestiq and the securing of U.S. rights for Saypha fillers.